Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-24 Purchase |
2025-02-24 5:52 pm |
Clearside Biomedical Inc. | CLSD | Thorp Clay Director |
15,000 | $0.92 | $13,800 | 176,141 (Direct) |
View |
| 2023-09-25 Purchase |
2023-09-25 4:34 pm |
Clearside Biomedical Inc. | CLSD | Thorp Clay Director |
10,000 | $0.86 | $8,600 | 3,585,562 (Indirect Direct) |
View |
| 2022-12-21 Purchase |
2022-12-21 4:26 pm |
Clearside Biomedical Inc. | CLSD | Thorp Clay Director |
14,000 | $1.019 | $14,266 | 3,575,562 (Indirect Direct) |
View |
| 2021-02-10 Sale(A) |
2022-12-19 7:40 pm |
Clearside Biomedical Inc. | CLSD | Thorp Clay Director |
32,873 | $4.43 | $145,627 | 4,951,547 (Direct) |
View |
| 2022-05-16 Purchase |
2022-05-17 9:06 pm |
Vigil Neuroscience Inc. | VIGL | Thorp Clay Director |
36,695 | $2.8454 | $104,411 | 1,559,030 (Indirect Direct) |
View |
| 2022-03-28 Purchase |
2022-03-28 4:44 pm |
Vigil Neuroscience Inc. | VIGL | Thorp Clay Director |
3,000 | $7.2014 | $21,604 | 1,522,335 (Indirect Direct) |
View |
| 2022-01-11 Purchase |
2022-01-11 9:20 pm |
Vigil Neuroscience Inc. | VIGL | Thorp Clay Director |
265,000 | $14 | $3,710,000 | 1,519,335 (Indirect) |
View |
| 2021-08-18 Purchase |
2021-08-18 6:07 pm |
PhaseBio Pharmaceuticals Inc | PHAS | Thorp Clay Director |
10,000 | $3 | $30,000 | 32,943 (Direct) |
View |
| 2021-02-10 Sale |
2021-02-12 5:22 pm |
Clearside Biomedical Inc. | CLSD | Thorp Clay Director |
32,873 | $4.43 | $145,627 | 3,441,521 (Indirect Direct) |
View |
| 2020-11-23 Purchase |
2020-11-24 4:04 pm |
PhaseBio Pharmaceuticals Inc | PHAS | Thorp Clay Director |
5,000 | $3.602 | $18,010 | 22,943 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-20 Option Award |
2024-06-21 4:15 pm |
N/A 2034-06-19 |
Clearside Biomedical Inc. | CLSD | Thorp Clay Director |
45,000 | $0 | 45,000 (Direct) |
View |
| 2023-06-22 Option Award |
2023-06-23 4:41 pm |
N/A 2033-06-21 |
Clearside Biomedical Inc. | CLSD | Thorp Clay Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-05-19 Exercise |
2023-05-19 4:18 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Thorp Clay Director |
3,750 | $0 | 3,581,733 (Direct) |
View |
| 2022-12-15 Other |
2022-12-19 7:41 pm |
N/A N/A |
Clearside Biomedical Inc. | CLSD | Thorp Clay Director |
1,415,029 | $0 | 4,976,591 (Indirect) |
View |
| 2022-06-22 Option Award |
2022-06-24 4:21 pm |
N/A 2032-06-21 |
Clearside Biomedical Inc. | CLSD | Thorp Clay Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2022-05-19 Option Award |
2022-05-20 4:46 pm |
N/A 2032-05-18 |
PhaseBio Pharmaceuticals Inc | PHAS | Thorp Clay Director |
21,250 | $0 | 21,250 (Direct) |
View |
| 2022-01-11 Conversion |
2022-01-11 9:20 pm |
N/A N/A |
Vigil Neuroscience Inc. | VIGL | Thorp Clay Director |
4,732,862 | $0 | 1,519,335 (Indirect) |
View |
Ownership |
2022-01-06 8:34 pm |
N/A N/A |
Vigil Neuroscience Inc. | VIGL | Thorp Clay Director |
0 | $0 | 1,254,335 (Indirect) |
View |
| 2021-06-10 Option Award |
2021-06-11 5:33 pm |
N/A 2031-06-09 |
Clearside Biomedical Inc. | CLSD | Thorp Clay Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2021-06-03 Option Award |
2021-06-04 6:03 pm |
N/A 2031-06-03 |
PhaseBio Pharmaceuticals Inc | PHAS | Thorp Clay Director |
14,000 | $0 | 14,000 (Direct) |
View |
| 2020-11-16 Other |
2020-11-18 7:19 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Thorp Clay Director |
65,127 | $0 | 2,495,989 (Indirect) |
View |
| 2020-06-18 Option Award |
2020-06-19 4:41 pm |
N/A 2030-06-17 |
Clearside Biomedical Inc. | CLSD | Thorp Clay Director 10% Owner |
25,000 | $0 | 25,000 (Direct) |
View |
| 2020-06-03 Option Award |
2020-06-05 7:02 pm |
N/A 2030-06-03 |
PhaseBio Pharmaceuticals Inc | PHAS | Thorp Clay Director |
16,000 | $0 | 16,000 (Direct) |
View |